Literature DB >> 23554196

Epidemic spread of multidrug-resistant tuberculosis in Johannesburg, South Africa.

Ben J Marais1, Charmaine K Mlambo, Nalin Rastogi, Thierry Zozio, Adriano G Duse, Thomas C Victor, Else Marais, Robin M Warren.   

Abstract

Numerous reports have documented isolated transmission events or clonal outbreaks of multidrug-resistant Mycobacterium tuberculosis strains, but knowledge of their epidemic spread remains limited. In this study, we evaluated drug resistance, strain diversity, and clustering rates in patients diagnosed with multidrug-resistant (MDR) tuberculosis (TB) at the National Health Laboratory Service (NHLS) Central TB Laboratory in Johannesburg, South Africa, between March 2004 and December 2007. Phenotypic drug susceptibility testing was done using the indirect proportion method, while each isolate was genotyped using a combination of spoligotyping and 12-MIRU typing (12-locus multiple interspersed repetitive unit typing). Isolates from 434 MDR-TB patients were evaluated, of which 238 (54.8%) were resistant to four first-line drugs (isoniazid, rifampin, ethambutol, and streptomycin). Spoligotyping identified 56 different strains and 28 clusters of variable size (2 to 71 cases per cluster) with a clustering rate of 87.1%. Ten clusters included 337 (77.6%) of all cases, with strains of the Beijing genotype being most prevalent (16.4%). Combined analysis of spoligotyping and 12-MIRU typing increased the discriminatory power (Hunter Gaston discriminatory index [HGDI] = 0.962) and reduced the clustering rate to 66.8%. Resolution of Beijing genotype strains was further enhanced with the 24-MIRU-VNTR (variable-number tandem repeat) typing method by identifying 15 subclusters and 19 unique strains from twelve 12-MIRU clusters. High levels of clustering among a variety of strains suggest a true epidemic spread of MDR-TB in the study setting, emphasizing the urgency of early diagnosis and effective treatment to reduce transmission within this community.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23554196      PMCID: PMC3716102          DOI: 10.1128/JCM.00200-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  46 in total

1.  A multidisciplinary method to map potential tuberculosis transmission 'hot spots' in high-burden communities.

Authors:  E J Murray; B J Marais; G Mans; N Beyers; H Ayles; P Godfrey-Faussett; S Wallman; V Bond
Journal:  Int J Tuberc Lung Dis       Date:  2009-06       Impact factor: 2.373

2.  Changing Mycobacterium tuberculosis population highlights clade-specific pathogenic characteristics.

Authors:  G D van der Spuy; K Kremer; S L Ndabambi; N Beyers; R Dunbar; B J Marais; P D van Helden; R M Warren
Journal:  Tuberculosis (Edinb)       Date:  2008-12-02       Impact factor: 3.131

3.  Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity.

Authors:  P R Hunter; M A Gaston
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

4.  The competitive cost of antibiotic resistance in Mycobacterium tuberculosis.

Authors:  Sebastien Gagneux; Clara Davis Long; Peter M Small; Tran Van; Gary K Schoolnik; Brendan J M Bohannan
Journal:  Science       Date:  2006-06-30       Impact factor: 47.728

5.  Whole-genome sequencing and social-network analysis of a tuberculosis outbreak.

Authors:  Jennifer L Gardy; James C Johnston; Shannan J Ho Sui; Victoria J Cook; Lena Shah; Elizabeth Brodkin; Shirley Rempel; Richard Moore; Yongjun Zhao; Robert Holt; Richard Varhol; Inanc Birol; Marcus Lem; Meenu K Sharma; Kevin Elwood; Steven J M Jones; Fiona S L Brinkman; Robert C Brunham; Patrick Tang
Journal:  N Engl J Med       Date:  2011-02-24       Impact factor: 91.245

Review 6.  Scaling up interventions to achieve global tuberculosis control: progress and new developments.

Authors:  Mario Raviglione; Ben Marais; Katherine Floyd; Knut Lönnroth; Haileyesus Getahun; Giovanni B Migliori; Anthony D Harries; Paul Nunn; Christian Lienhardt; Steve Graham; Jeremiah Chakaya; Karin Weyer; Stewart Cole; Stefan H E Kaufmann; Alimuddin Zumla
Journal:  Lancet       Date:  2012-05-19       Impact factor: 79.321

Review 7.  The chemotherapy of tuberculosis: past, present and future.

Authors:  D Mitchison; G Davies
Journal:  Int J Tuberc Lung Dis       Date:  2012-06       Impact factor: 2.373

8.  Predominance of a single genotype of Mycobacterium tuberculosis in regions of Southern Africa.

Authors:  V Chihota; L Apers; S Mungofa; W Kasongo; I M Nyoni; R Tembwe; G Mbulo; M Tembo; E M Streicher; G D van der Spuy; T C Victor; P van Helden; R M Warren
Journal:  Int J Tuberc Lung Dis       Date:  2007-03       Impact factor: 2.373

9.  Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis.

Authors:  Philip Supply; Caroline Allix; Sarah Lesjean; Mara Cardoso-Oelemann; Sabine Rüsch-Gerdes; Eve Willery; Evgueni Savine; Petra de Haas; Henk van Deutekom; Solvig Roring; Pablo Bifani; Natalia Kurepina; Barry Kreiswirth; Christophe Sola; Nalin Rastogi; Vincent Vatin; Maria Cristina Gutierrez; Maryse Fauville; Stefan Niemann; Robin Skuce; Kristin Kremer; Camille Locht; Dick van Soolingen
Journal:  J Clin Microbiol       Date:  2006-09-27       Impact factor: 5.948

10.  Emergence of increased resistance and extensively drug-resistant tuberculosis despite treatment adherence, South Africa.

Authors:  Alistair D Calver; Alecia A Falmer; Megan Murray; Odelia J Strauss; Elizabeth M Streicher; Madelene Hanekom; Thelma Liversage; Mothusi Masibi; Paul D van Helden; Robin M Warren; Thomas C Victor
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

View more
  37 in total

1.  The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis.

Authors:  Gwenan M Knight; Caroline Colijn; Sourya Shrestha; Mariam Fofana; Frank Cobelens; Richard G White; David W Dowdy; Ted Cohen
Journal:  Clin Infect Dis       Date:  2015-10-15       Impact factor: 9.079

Review 2.  [Drug-resistant tuberculosis. Epidemiology, diagnostics and therapy].

Authors:  M P Grobusch; F Schaumburg; E Altpeter; S Bélard
Journal:  Internist (Berl)       Date:  2016-02       Impact factor: 0.743

3.  Diversity of CRISPR/Cas system in Clostridium perfringens.

Authors:  Jinzhao Long; Yake Xu; Liuyang Ou; Haiyan Yang; Yuanlin Xi; Shuaiyin Chen; Guangcai Duan
Journal:  Mol Genet Genomics       Date:  2019-05-27       Impact factor: 3.291

Review 4.  Exploring the usefulness of molecular epidemiology of tuberculosis in Africa: a systematic review.

Authors:  Bourahima Kone; Anou M Somboro; Jane L Holl; Bocar Baya; Antieme Acg Togo; Yeya Dit Sadio Sarro; Bassirou Diarra; Ousmane Kodio; Robert L Murphy; William Bishai; Mamoudou Maiga; Seydou Doumbia
Journal:  Int J Mol Epidemiol Genet       Date:  2020-06-15

5.  Extensively drug-resistant tuberculosis in South Africa: genomic evidence supporting transmission in communities.

Authors:  Sara C Auld; N Sarita Shah; Barun Mathema; Tyler S Brown; Nazir Ismail; Shaheed Vally Omar; James C M Brust; Kristin N Nelson; Salim Allana; Angela Campbell; Koleka Mlisana; Pravi Moodley; Neel R Gandhi
Journal:  Eur Respir J       Date:  2018-10-18       Impact factor: 16.671

Review 6.  Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria.

Authors:  Tomasz Jagielski; Alina Minias; Jakko van Ingen; Nalin Rastogi; Anna Brzostek; Anna Żaczek; Jarosław Dziadek
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

7.  Transmission of Extensively Drug-Resistant Tuberculosis in South Africa.

Authors:  N Sarita Shah; Sara C Auld; James C M Brust; Barun Mathema; Nazir Ismail; Pravi Moodley; Koleka Mlisana; Salim Allana; Angela Campbell; Thuli Mthiyane; Natashia Morris; Primrose Mpangase; Hermina van der Meulen; Shaheed V Omar; Tyler S Brown; Apurva Narechania; Elena Shaskina; Thandi Kapwata; Barry Kreiswirth; Neel R Gandhi
Journal:  N Engl J Med       Date:  2017-01-19       Impact factor: 91.245

Review 8.  Tuberculosis in children.

Authors:  Ben J Marais; H Simon Schaaf
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-18       Impact factor: 6.915

9.  Multilocus microsatellite genotyping array for investigation of genetic epidemiology of Pneumocystis jirovecii.

Authors:  Christian M Parobek; Linda Y Jiang; Jaymin C Patel; Miriam J Alvarez-Martínez; Jose M Miro; William Worodria; Alfred Andama; Serena Fong; Laurence Huang; Steven R Meshnick; Steve M Taylor; Jonathan J Juliano
Journal:  J Clin Microbiol       Date:  2014-02-12       Impact factor: 5.948

10.  Treatment outcomes of multidrug-resistant tuberculosis patients in Gauteng, South Africa.

Authors:  E Marais; C K Mlambo; J J Lewis; N Rastogi; T Zozio; M P Grobusch; A Duse; T Victor; R W Warren
Journal:  Infection       Date:  2013-12-21       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.